Virginia Wealth Management Group, Inc. Amgen Inc Transaction History

Virginia Wealth Management Group, Inc.

$122 Million
Q2 2024

A detailed history of Virginia Wealth Management Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Virginia Wealth Management Group, Inc. holds 8,377 shares of AMGN stock, worth $2.68 Million. This represents 2.15% of its overall portfolio holdings.

Number of Shares

8,377

Previous 8,436 0.7%

Holding current value

$2.68 Million

Previous $2.4 Million 9.13%

% of portfolio

2.15%

Previous 1.96%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $15,502 - $18,839	-59 Reduced 0.7%	8,377 $2.62 Million
Q1 2024 Apr 25, 2024	SELL	$268.87 - $324.56 $109,430 - $132,095	-407 Reduced 4.6%	8,436 $2.4 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $584,274 - $659,131	-2,285 Reduced 20.53%	8,843 $2.55 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $3,935 - $4,886	18 Added 0.16%	11,128 $2.99 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $11,356 - $13,428	-53 Reduced 0.47%	11,110 $2.47 Million
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $53,286 - $64,947	236 Added 2.16%	11,163 $2.7 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $37,102 - $47,143	162 Added 1.5%	10,927 $2.87 Million
Q3 2022 Oct 19, 2022	SELL	$224.46 - $253.15 $87,090 - $98,222	-388 Reduced 3.48%	10,765 $2.43 Million
Q2 2022 Jan 04, 2023	SELL	$230.71 - $256.74 $402,358 - $447,754	-1,744 Reduced 16.2%	9,021 $2.2 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $490,720 - $546,085	2,127 Added 23.57%	11,153 $2.71 Million
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $156,558 - $173,194	714 Added 8.59%	9,026 $2.26 Million
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $1.65 Million - $1.89 Million	8,312 New	8,312 $1.87 Million

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Wealth Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virginia Wealth Management Group, Inc. with notifications on news.

Account

Virginia Wealth Management Group, Inc. Amgen Inc Transaction History